265. 脂肪萎縮症 Lipodystrophy Clinical trials / Disease details
臨床試験数 : 116 / 薬物数 : 170 - (DrugBank : 61) / 標的遺伝子数 : 26 - 標的パスウェイ数 : 97
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04860063 (ClinicalTrials.gov) | April 2021 | 17/4/2021 | Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. | Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in People Living With HIV. | Metabolic Syndrome;HIV-1-infection;Glucose Intolerance;Dyslipidemias;Lipodystrophy;Lipoatrophy | Drug: Berberine;Drug: Placebo | Hospital Civil de Guadalajara | NULL | Not yet recruiting | 18 Years | 60 Years | All | 40 | Phase 3 | NULL |